Several panelists thought that the cancer signal may have reflected an ascertainment bias, and, further, that a young homozygous FH population would be less susceptible to an elevated cancer risk.

FORBES: FDA Panel Recommends Approval Of Mipomersen For Familial Hypercholesterolemia